David Sinclair plans to test whole-body rejuvenation drugs in XPrize competition using chemical reprogramming
By
Antonio Regalado
An everything bagel for the brain. Substantive, layered, well-seasoned.
Summary
David Sinclair plans to test whole-body rejuvenation drugs in the XPrize competition using a technology called chemical reprogramming. This approach uses drugs to mimic embryonic genes and epigenetically restore cells, potentially reaching all cells in the body through the bloodstream. Sinclair's team has been conducting extensive animal studies with an oral agent and aims to compete in the XPrize. However, some experts have expressed caution about the chemical process as used in labs.
Key quotes
· 2 pulledWhat we're aiming to do is to epigenetically restore the animal and eventually the person.
It is true that we've been doing extensive animal studies with the oral agent and are looking to compete in the XPrize.
You might also wanna read
Method to reverse cellular ageing is about to be tested in humans
Power-over-Skin: Full-Body Wearables Powered by Intra-Body RF Energy (2024)
OpenAI and Retro Biosciences Develop AI Model That Achieves 50x Improvement in Stem Cell Reprogramming
OpenAI collaborated with Retro Biosciences to develop GPT-4b micro, a specialized AI model for protein engineering. The AI-designed proteins
openai.com·9mo agoEfficient mRNA delivery to resting T cells to reverse HIV latency
Startup Bexorg uses intact postmortem human brains for neurodegenerative drug testing
A startup called Bexorg is using intact brains from deceased human donors to test drugs for neurodegenerative diseases. By restoring blood f
science.org·18d agoStartup Bexorg uses intact postmortem human brains for neurodegenerative drug testing
A startup called Bexorg is using intact brains from deceased human donors to test drugs for neurodegenerative diseases. By restoring blood f
science.org·18d ago
International Collaboration Advances Synthetic Cell Research
The article discusses the emerging field of synthetic cell (SynCell) research, which aims to build artificial cells from molecular component
nature.com·8mo ago